Evonik to Expand Lafayette Operations, Add 80 Jobs

Germany-based Evonik says it will expand its pharmaceutical production facility in Lafayette and create 80 jobs. The company, which produces the active ingredients for medications, says the total investment is $220 million with the U.S. government funding up to $150 million toward the project through its Biomedical Advanced Research and Development Authority.

The plant will build produce lipids for mRNA-based therapies in the U.S. Lipids are molecules that contain hydrocarbons and make up the building blocks of the structure and function of living cells.

Full Story courtesy of Inside Indiana Business